468 related articles for article (PubMed ID: 17895758)
21. Primary retroperitoneal myxoid/round cell liposarcoma is a nonexisting disease: an immunohistochemical and molecular biological analysis.
de Vreeze RS; de Jong D; Tielen IH; Ruijter HJ; Nederlof PM; Haas RL; van Coevorden F
Mod Pathol; 2009 Feb; 22(2):223-31. PubMed ID: 18820664
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of MDM2 and CDK4 amplification by real-time PCR on paraffin wax-embedded material: a potential tool for the diagnosis of atypical lipomatous tumours/well-differentiated liposarcomas.
Hostein I; Pelmus M; Aurias A; Pedeutour F; Mathoulin-Pélissier S; Coindre JM
J Pathol; 2004 Jan; 202(1):95-102. PubMed ID: 14694526
[TBL] [Abstract][Full Text] [Related]
23. Immunophenotypic characterization of high grade pleomorphic sarcomas: a demographic and immunohistochemical study in a major referral center of Pakistan.
Shah H; Pervez S
J Pak Med Assoc; 2005 Mar; 55(3):101-4. PubMed ID: 15852744
[TBL] [Abstract][Full Text] [Related]
24. Well-differentiated and dedifferentiated liposarcomas with prominent myxoid stroma: analysis of 56 cases.
Sioletic S; Dal Cin P; Fletcher CD; Hornick JL
Histopathology; 2013 Jan; 62(2):287-93. PubMed ID: 23020289
[TBL] [Abstract][Full Text] [Related]
25. Adult-type rhabdomyosarcoma: analysis of 57 cases with clinicopathologic description, identification of 3 morphologic patterns and prognosis.
Stock N; Chibon F; Binh MB; Terrier P; Michels JJ; Valo I; Robin YM; Guillou L; Ranchère-Vince D; Decouvelaere AV; Collin F; Birtwisle-Peyrottes I; Gregoire F; Aurias A; Coindre JM
Am J Surg Pathol; 2009 Dec; 33(12):1850-9. PubMed ID: 19898221
[TBL] [Abstract][Full Text] [Related]
26. alpha-fetoprotein expression in a dedifferentiated liposarcoma.
Bosco M; Allia E; Coindre JM; Odasso C; Pagani A; Pacchioni D
Virchows Arch; 2006 Apr; 448(4):517-20. PubMed ID: 16489442
[TBL] [Abstract][Full Text] [Related]
27. MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes: a comparative analysis of 559 soft tissue neoplasms with genetic data.
Binh MB; Sastre-Garau X; Guillou L; de Pinieux G; Terrier P; Lagacé R; Aurias A; Hostein I; Coindre JM
Am J Surg Pathol; 2005 Oct; 29(10):1340-7. PubMed ID: 16160477
[TBL] [Abstract][Full Text] [Related]
28. Retroperitoneal dedifferentiated liposarcoma with osteosarcomatous components: a case report.
Fujii T; Arai T; Sakon M; Sawano S; Momose Y; Ishii K; Miwa S
Int J Clin Exp Pathol; 2013; 6(7):1427-31. PubMed ID: 23826426
[TBL] [Abstract][Full Text] [Related]
29. CDK4 amplification predicts recurrence of well-differentiated liposarcoma of the abdomen.
Lee S; Park H; Ha SY; Paik KY; Lee SE; Kim JM; Park JB; Kwon CH; Joh JW; Choi YL; Kim SJ
PLoS One; 2014; 9(8):e99452. PubMed ID: 25121597
[TBL] [Abstract][Full Text] [Related]
30. Dedifferentiated liposarcoma with meningothelial-like whorls, metaplastic bone formation, and CDK4, MDM2, and p16 expression: a morphologic and immunohistochemical study.
Thway K; Robertson D; Thway Y; Fisher C
Am J Surg Pathol; 2011 Mar; 35(3):356-63. PubMed ID: 21317707
[TBL] [Abstract][Full Text] [Related]
31. A Proposed Staging System for Improved Prognostication of MDM2-amplified Liposarcoma.
Tucci JJ; Dashti NK; Cates JMM
Am J Surg Pathol; 2021 Jan; 45(1):101-107. PubMed ID: 32796171
[TBL] [Abstract][Full Text] [Related]
32. p16 Immunohistochemistry is Less Useful Than MDM2 and CDK4 to Distinguish Dedifferentiated Liposarcomas From Other Retroperitoneal Mimics.
Kang Y; Horvai AE
Appl Immunohistochem Mol Morphol; 2017 Jan; 25(1):58-63. PubMed ID: 26509911
[TBL] [Abstract][Full Text] [Related]
33. Prognostic features of pediatric soft-tissue sarcomas.
Neifeld JP; Godwin D; Berg JW; Salzberg AM
Surgery; 1985 Jul; 98(1):93-7. PubMed ID: 4012611
[TBL] [Abstract][Full Text] [Related]
34. Well-differentiated liposarcoma with low-grade osteosarcomatous component: an underrecognized variant.
Yoshida A; Ushiku T; Motoi T; Shibata T; Fukayama M; Tsuda H
Am J Surg Pathol; 2010 Sep; 34(9):1361-6. PubMed ID: 20697254
[TBL] [Abstract][Full Text] [Related]
35. Clinical and biological significance of CDK4 amplification in well-differentiated and dedifferentiated liposarcomas.
Italiano A; Bianchini L; Gjernes E; Keslair F; Ranchere-Vince D; Dumollard JM; Haudebourg J; Leroux A; Mainguené C; Terrier P; Chibon F; Coindre JM; Pedeutour F
Clin Cancer Res; 2009 Sep; 15(18):5696-703. PubMed ID: 19737942
[TBL] [Abstract][Full Text] [Related]
36. Pleomorphic leiomyosarcoma: clinicopathologic and immunohistochemical study with special emphasis on its distinction from ordinary leiomyosarcoma and malignant fibrous histiocytoma.
Oda Y; Miyajima K; Kawaguchi K; Tamiya S; Oshiro Y; Hachitanda Y; Oya M; Iwamoto Y; Tsuneyoshi M
Am J Surg Pathol; 2001 Aug; 25(8):1030-8. PubMed ID: 11474287
[TBL] [Abstract][Full Text] [Related]
37. Dedifferentiated Liposarcoma With Rhabdomyosarcomatous Differentiation Producing HCG: A Case Report of a Diagnostic Pitfall.
Maryamchik E; Lyapichev KA; Halliday B; Rosenberg AE
Int J Surg Pathol; 2018 Aug; 26(5):448-452. PubMed ID: 29532681
[TBL] [Abstract][Full Text] [Related]
38. Molecular Characterization of a Rare Dedifferentiated Liposarcoma With Rhabdomyosarcomatous Differentiation in a 24 Year Old.
Olson N; Gularte-Mérida R; Selenica P; Da Cruz Paula A; Alemar B; Weigelt B; Lefferts J; Linos K
Int J Surg Pathol; 2020 Jun; 28(4):454-463. PubMed ID: 31801397
[No Abstract] [Full Text] [Related]
39. Establishment and characterization of a novel dedifferentiated liposarcoma cell line, NDDLS-1.
Ariizumi T; Ogose A; Kawashima H; Hotta T; Li G; Xu Y; Hirose T; Endo N
Pathol Int; 2011 Aug; 61(8):461-8. PubMed ID: 21790860
[TBL] [Abstract][Full Text] [Related]
40. [Dedifferentiated liposarcoma with inflammatory myofibroblastic tumor-like features: a clinicopathological analysis of five cases].
Si HP; Wang Z; Fan QH; Zhang YF; Yang DQ; Zhang ZH; Gong QX
Zhonghua Bing Li Xue Za Zhi; 2019 Apr; 48(4):282-287. PubMed ID: 30955263
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
